Cerity Partners’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-46,632
Closed -$660K 3250
2025
Q4
$660K Buy
46,632
+4,800
+11% +$69.5K ﹤0.01% 1932
2025
Q3
$619K Hold
41,832
﹤0.01% 1852
2025
Q2
$633K Hold
41,832
﹤0.01% 1747
2025
Q1
$602K Buy
41,832
+1,832
+5% +$28K ﹤0.01% 1663
2024
Q4
$606K Hold
40,000
﹤0.01% 1656
2024
Q3
$658K Hold
40,000
﹤0.01% 1623
2024
Q2
$656K Hold
40,000
﹤0.01% 1408
2024
Q1
$666K Hold
40,000
﹤0.01% 1461
2023
Q4
$598K Hold
40,000
﹤0.01% 1196
2023
Q3
$580K Sell
40,000
-500
-1% -$7.48K ﹤0.01% 926
2023
Q2
$618K Hold
40,500
﹤0.01% 1093
2023
Q1
$613K Hold
40,500
﹤0.01% 1197
2022
Q4
$562K Buy
+40,500
New +$572K ﹤0.01% 893

Other funds holding BCAT

Cerity Partners's BCAT Position: Q1 2026 in Review

Cerity Partners sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q1 2026, closing a stake of 46,632 shares — an estimated $660K sold.

Cerity Partners first reported a position in BCAT in Q4 2022 and held it in 13 quarters. The position peaked at $666K in Q1 2024. 100 funds tracked by Wall St. Rank hold BCAT as of Q1 2026.

  • Cerity Partners reported no remaining BlackRock Capital Allocation Term Trust position as of Q1 2026 after selling out during the quarter.
  • Cerity Partners sold 46,632 BlackRock Capital Allocation Term Trust shares in Q1 2026, an estimated $660K.
  • Cerity Partners first reported a position in BlackRock Capital Allocation Term Trust in Q4 2022 and held it in 13 quarters.
  • Cerity Partners's BlackRock Capital Allocation Term Trust position peaked at $666K in Q1 2024.
  • 100 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q1 2026.

Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.